Merck: A Pharma Giant Trading At A Decade-Low Valuation While Executing Its Post-Keytruda Playbook

Merck (MRK) looks undervalued amid 2028 Keytruda patent fears—strong Q3 results, pipeline wins, and 12x P/E suggest upside.
FinanceBuzz on MSN

15 low-stress jobs for baby boomers who want to work from home

Retirement doesn't mean you have to stop working. Explore 15 remote job options curated for baby boomers and embark on a ...
Technobezz on MSN

iPhone fold: Everything we know so far

If the leaked dimensions are accurate, the iPhone Fold could be Apple's thinnest device ever. Reports suggest it would measure just 4.5mm when unfolded and around 9mm when closed. For comparison, that ...